Do you need a starting point for a Serialization User Requirement Spec (URS)?

October 10, 2012

One of the challenges to starting any User Requirement Specification (URS) is to envision a structure which can allow for traceability as the project continues.  The attached sample URS is a starting point which is laid out in tabular format to allow easy integration into a Requirements Traceability Matrix (RTM).  The URS is separated into logical sections to prompt the writer to consider what requirements are appropriate for their specific implementation an organized way.  Requirement examples provided in each section are intended to provide some initial ideas which can be further embellished and added to as appropriate for a project.

Once a structure has been established, the other major challenge is to write good requirements. The key attributes of good requirements are:
 
  • Each requirement should be concise.  No more than 200 words.
  • Each requirement should be measurable.  Requirements like “User Friendly” are hard to test.
  • Requirements should only be stated once.  Multiple requirements stating the same need are often contradictory.

This document does not necessarily include all the requirements for your system, but I hope you find this a better starting point than a blank screen!

Download the Microsoft Word version here:

Screenshot of 'Considering URS document'

TAGS:

July 12, 2021

Pedaling While Fixing a Flat: Conducting a Good FDA Meeting Under Bad Circumstances

Before using a significant risk medical device in a clinical study, Sponsors must first obtain FDA approval. Frequently, the request for an investigational device exemption (IDE) is disapproved, and...

IND Readiness Isn't a Checkbox Exercise, It's a Regulatory Risk Management Strategy

Why Sponsors Should Pressure-Test Their IND Before Submission For many sponsors, the Investigational New Drug (IND) application is viewed as a procedural milestone, the point at which a development...

September 2, 2025

MLR Submission Checklist: Preparing for Speed and Compliance

Pharmaceutical, biotech, and MedTech companies invest significant time and resources into developing promotional materials, only to face avoidable delays during the Medical, Legal, and Regulatory...